Leukaemia Trial, Recruiting (NCT06390306)

Leukaemia Trial, Recruiting NCT06390306 Sponsor: Peking University People's Hospital Condition: Leukaemia

Printed from Voxsanity (voxsanity.com.au) — NCT06390306 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Leukaemia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
Your leukemia has tested positive for the Philadelphia chromosome or a specific gene change called BCR::ABL
Your kidney function is within an acceptable range, based on blood or urine tests (confirm with trial site)
Your liver function, including bilirubin levels, is within an acceptable range based on blood tests (confirm with trial site)
Your pancreas enzyme levels (amylase and lipase) are within an acceptable range based on blood tests (confirm with trial site)
Your heart is pumping well enough (over 50% efficiency) and your heart's electrical activity, measured by an ECG, is within a normal range for your sex (confirm with trial site)

Who may not be able to join:

You have another medical condition that requires treatment which could interfere with the type of medication used in this trial (confirm with trial site)
You have been diagnosed with another type of cancer
You have previously had a stem cell transplant using cells from a donor (allogeneic transplant)
Your disease is only present outside of the bone marrow, with no involvement of the bone marrow itself (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Qian Jiang, MD, Peking University People's Hospital

Phone: +861088326006

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06390306

Sponsor: Peking University People's Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Leukaemia

Trial contact: +861088326006

More information: https://clinicaltrials.gov/study/NCT06390306

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
Your leukemia has tested positive for the Philadelphia chromosome or a specific gene change called BCR::ABL
Your kidney function is within an acceptable range, based on blood or urine tests (confirm with trial site)
Your liver function, including bilirubin levels, is within an acceptable range based on blood tests (confirm with trial site)
Your pancreas enzyme levels (amylase and lipase) are within an acceptable range based on blood tests (confirm with trial site)
Your heart is pumping well enough (over 50% efficiency) and your heart's electrical activity, measured by an ECG, is within a normal range for your sex (confirm with trial site)

Who may not be able to join:

You have another medical condition that requires treatment which could interfere with the type of medication used in this trial (confirm with trial site)
You have been diagnosed with another type of cancer
You have previously had a stem cell transplant using cells from a donor (allogeneic transplant)
Your disease is only present outside of the bone marrow, with no involvement of the bone marrow itself (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peking University People's Hospital

Registry

ClinicalTrials.gov

Start date

1 July 2024

Est. completion

1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Major hematologic response (MaHR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov